Scholarlink

Acute Type B aortic dissection (aTBAD) remains a potentially lethal diagnosis, requiring thorough understanding, rapid diagnosis, and treatment. Thoracic endovascular aortic repair (TEVAR) has revolutionized the treatment of complicated aTBAD; however, important areas of active investigation remain regarding techniques, devices, and extent of coverage. Furthermore, the role of TEVAR for uncomplicated aTBAD has yet to be defined. Endovascular therapy for chronic Type B aortic dissection (cTBAD) is feasible, but has many more challenges, and open aortic replacement continues to be the optimal therapy for patients who can tolerate the procedure.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Operative Management of Type B Dissection

  • 章节

  • 发表日期：

    2026年

查看全文
  • Alexander P. Nissen,
  • Bradley G. Leshnower

摘要

Acute Type B aortic dissection (aTBAD) remains a potentially lethal diagnosis, requiring thorough understanding, rapid diagnosis, and treatment. Thoracic endovascular aortic repair (TEVAR) has revolutionized the treatment of complicated aTBAD; however, important areas of active investigation remain regarding techniques, devices, and extent of coverage. Furthermore, the role of TEVAR for uncomplicated aTBAD has yet to be defined. Endovascular therapy for chronic Type B aortic dissection (cTBAD) is feasible, but has many more challenges, and open aortic replacement continues to be the optimal therapy for patients who can tolerate the procedure.